CIK 2092021
Seven Fleet Capital Management LP
Institutional 13F holdings & portfolio
Holdings
85
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–50 of 85
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 66K | $1M+ | SH |
| SLNO | SOLENO THERAPEUTICS INC | 76K | $1M+ | SH |
| LQDA | LIQUIDIA CORPORATION | 91K | $1M+ | SH |
| CGON | CG ONCOLOGY INC | 76K | $1M+ | SH |
| CMPX | COMPASS THERAPEUTICS INC | 569K | $1M+ | SH |
| EXEL | EXELIXIS INC | 69K | $1M+ | SH |
| AXSM | AXSOME THERAPEUTICS INC | 13K | $1M+ | SH |
| TYRA | TYRA BIOSCIENCES INC | 80K | $1M+ | SH |
| COGT | COGENT BIOSCIENCES INC | 54K | $1M+ | SH |
| TNGX | TANGO THERAPEUTICS INC | 215K | $1M+ | SH |
| XNCR | XENCOR INC | 110K | $1M+ | SH |
| PHVS | PHARVARIS N V | 55K | $1M+ | SH |
| TERN | TERNS PHARMACEUTICALS INC | 37K | $1M+ | SH |
| BLTE | BELITE BIO INC | 9K | $1M+ | SH |
| DYN | DYNE THERAPEUTICS INC | 70K | $1M+ | SH |
| NUVL | NUVALENT INC | 13K | $1M+ | SH |
| ASND | ASCENDIS PHARMA A/S | 6K | $1M+ | SH |
| FOLD | AMICUS THERAPEUTICS INC | 83K | $1M+ | SH |
| PCVX | VAXCYTE INC | 25K | $1M+ | SH |
| AVTX | AVALO THERAPEUTICS INC | 63K | $1M+ | SH |
| IKT | INHIBIKASE THERAPEUTICS INC | 534K | $1M+ | SH |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 2K | $1M+ | SH |
| GERN | GERON CORP | 778K | $1M+ | SH |
| KRYS | KRYSTAL BIOTECH INC | 4K | $500K+ | SH |
| LONA | ATHIRA PHARMA INC | 128K | $500K+ | SH |
| TSHA | TAYSHA GENE THERAPIES INC | 167K | $500K+ | SH |
| SLN | SILENCE THERAPEUTICS PLC | 148K | $500K+ | SH |
| ZURA | ZURA BIO LTD | 167K | $500K+ | SH |
| AGIO | AGIOS PHARMACEUTICALS INC | 32K | $500K+ | SH |
| PRAX | PRAXIS PRECISION MEDICINES I | 3K | $500K+ | SH |
| CELC | CELCUITY INC | 8K | $500K+ | SH |
| KALV | KALVISTA PHARMACEUTICALS INC | 48K | $500K+ | SH |
| PALI | PALISADE BIO INC | 328K | $500K+ | SH |
| RLMD | RELMADA THERAPEUTICS INC | 154K | $500K+ | SH |
| PTGX | PROTAGONIST THERAPEUTICS INC | 8K | $500K+ | SH |
| CDTX | CIDARA THERAPEUTICS INC | 3K | $500K+ | SH |
| CYTK | CYTOKINETICS INC | 10K | $500K+ | SH |
| NKTR | NEKTAR THERAPEUTICS | 15K | $500K+ | SH |
| UTHR | UNITED THERAPEUTICS CORP DEL | 130K | $500K+ | SH |
| RLAY | RELAY THERAPEUTICS INC | 73K | $500K+ | SH |
| DNTH | DIANTHUS THERAPEUTICS INC | 15K | $500K+ | SH |
| MBX | MBX BIOSCIENCES INC | 18K | $500K+ | SH |
| MLYS | MINERALYS THERAPEUTICS INC | 15K | $500K+ | SH |
| EOLS | EVOLUS INC | 82K | $500K+ | SH |
| ZYME | ZYMEWORKS INC | 21K | $500K+ | SH |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 57K | $100K–$500K | SH |
| VRDN | VIRIDIAN THERAPEUTICS INC | 15K | $100K–$500K | SH |
| PRTA | PROTHENA CORP PLC | 43K | $100K–$500K | SH |
| NRIX | NURIX THERAPEUTICS INC | 20K | $100K–$500K | SH |
| SVRA | SAVARA INC | 63K | $100K–$500K | SH |